How essential is kratom availability and use during COVID-19? Use pattern analysis based on survey and social media data

References

• Jansen KL, Prast CJ. Ethnopharmacology of kratom and the Mitragyna alkaloids. J Ethnopharmacol. 1988;23(1):115–119.
   PubMed Web of Science ®Google Scholar
• Singh D, Narayanan S, Muller CP, et al. Motives for using Kratom (Mitragyna speciosa Korth.) among regular users in Malaysia. J Ethnopharmacol. 2019;233:34–40.
   PubMed Web of Science ®Google Scholar
• Suwanlert S. A study of kratom eaters in Thailand. Bull Narc. 1975;27(3):21–27.
   PubMedGoogle Scholar
• Veltri C, Grundmann O. Current perspectives on the impact of Kratom use. SAR. 2019;10:23–31.
   Google Scholar
• Grundmann O. Patterns of Kratom use and health impact in the US-results from an online survey. Drug Alcohol Depend. 2017;176:63–70.
   PubMed Web of Science ®Google Scholar
• Kruegel AC, Grundmann O. The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology. 2018;134:108–120.
   PubMed Web of Science ®Google Scholar
• Kruegel AC, Uprety R, Grinnell SG, et al. 7-hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects. ACS Cent Sci. 2019;5(6):992–1001.
   PubMed Web of Science ®Google Scholar
• Singh D, Narayanan S, Vicknasingam B. Traditional and non-traditional uses of Mitragynine (Kratom): a survey of the literature. Brain Res Bull. 2016;126(1):41–46.
   PubMed Web of Science ®Google Scholar
• Todd DA, Kellogg JJ, Wallace ED, et al. Chemical composition and biological effects of kratom (Mitragyna speciosa): in vitro studies with implications for efficacy and drug interactions. Sci Rep. 2020;10(1):19158.
   PubMed Web of Science ®Google Scholar
• Covvey JR, Vogel SM, Peckham AM, Evoy KE. Prevalence and characteristics of self-reported kratom use in a representative US general population sample. Journal of Addictive Diseases. 2020;38(4):506–513.
   PubMed Web of Science ®Google Scholar
• Palamar JJ. Past-year kratom use in the U.S.: estimates from a nationally representative sample. Am J Prev Med. 2021;61(2):240–245.
   PubMed Web of Science ®Google Scholar
• Schimmel J, Amioka E, Rockhill K, et al. Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study. Addiction (Abingdon, England). 2021;116(1):176–181.
   PubMed Web of Science ®Google Scholar
• Bath R, Bucholz T, Buros AF, et al. Self-reported health diagnoses and demographic correlates with kratom use: results from an online survey. J Addict Med. 2020;14(3):244–252.
   PubMed Web of Science ®Google Scholar
• Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008;103(6):1048–1050.
   PubMed Web of Science ®Google Scholar
• Coe MA, Pillitteri JL, Sembower MA, Gerlach KK, Henningfield JE. Kratom as a substitute for opioids: results from an online survey. Drug Alcohol Depend. 2019;202:24–32.
   PubMed Web of Science ®Google Scholar
• Garcia-Romeu A, Cox DJ, Smith KE, Dunn KE, Griffiths RR. Kratom (Mitragyna speciosa): user demographics, use patterns, and implications for the opioid epidemic. Drug Alcohol Depend. 2020;208:107849.
   PubMed Web of Science ®Google Scholar
• Smith KE, Lawson T. Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program. Drug Alcohol Depend. 2017;180:340–348.
   PubMed Web of Science ®Google Scholar
• Obeng S, Wilkerson JL, León F, et al. Pharmacological comparison of mitragynine and 7-hydroxymitragynine: in vitro affinity and efficacy for μ-opioid receptor and opioid-like behavioral effects in rats. J Pharmacol Exp Ther. 2021;376(3):410–427.
   PubMed Web of Science ®Google Scholar
• Basiliere S, Kerrigan S. CYP450-mediated metabolism of mitragynine and investigation of metabolites in human urine. J Anal Toxicol. 2020;44(4):301–313.
   PubMed Web of Science ®Google Scholar
• Behnood-Rod A, Chellian R, Wilson R, et al. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats. Drug Alcohol Depend. 2020;215:108235.
   PubMed Web of Science ®Google Scholar
• Henningfield JE, Grundmann O, Babin JK, Fant RV, Wang DW, Cone EJ. Risk of death associated with kratom use compared to opioids. Prev Med. 2019;128:105851.
   PubMed Web of Science ®Google Scholar
• Henningfield JE, Fant RV, Wang DW. The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research. Psychopharmacology. Feb 2018;235(2):573–589.
   PubMed Web of Science ®Google Scholar
• Vicknasingam B, Chooi WT, Rahim AA, et al. Kratom and pain tolerance: a randomized, placebo-controlled, double-blind study. The Yale J Biol Med. 2020;93(2):229–238.
   PubMed Web of Science ®Google Scholar
• Ahmad K, Aziz Z. Mitragyna speciosa use in the northern states of Malaysia: a cross-sectional study. J Ethnopharmacol. 2012;141(1):446–450.
   PubMed Web of Science ®Google Scholar
• Singh D, Muller CP, Vicknasingam BK. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug Alcohol Depend. 2014;139:132–137.
   PubMed Web of Science ®Google Scholar
• Stanciu CN, Gnanasegaram SA, Ahmed S, Penders T. Kratom withdrawal: a systematic review with case series. J Psychoactive Drugs. 2019;51(1):12–18.
   PubMed Web of Science ®Google Scholar
• Weiss ST, Douglas HE. Treatment of kratom withdrawal and dependence with buprenorphine/naloxone: a case series and systematic literature review. Journal of Addiction Medicine. 2021;15(2):167–172.
   PubMed Web of Science ®Google Scholar
• Smith KE, Rogers JM, Strickland JC, Epstein DH. When an obscurity becomes a trend: social-media descriptions of tianeptine use and associated atypical drug use. Am J Drug Alcohol Abuse. 2021;47(4):455–466.
   PubMed Web of Science ®Google Scholar
• Griffin OH, Webb ME. The scheduling of kratom and selective use of data. J Psychoactive Drugs. 2018;50(2):114–120.
   PubMed Web of Science ®Google Scholar
• Sharma A, McCurdy CR. Assessing the therapeutic potential and toxicity of Mitragyna speciosa in opioid use disorder. Expert Opin Drug Metab Toxicol. 2021;17(3):255–257.
   PubMed Web of Science ®Google Scholar
• Singh D, Narayanan S, Vicknasingam B, Corazza O, Santacroce R, Roman-Urrestarazu A. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia. Hum Psychopharmacol. 2017;32(3):e2582,1–6.
   PubMed Web of Science ®Google Scholar
• Smith KE, Rogers JM, Strickland JC, Epstein DH. When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use. Am J Drug Alcohol Abuse. 2021;47(4):455–466.
   PubMed Web of Science ®Google Scholar
• Swogger MT, Hart E, Erowid F, et al. Experiences of kratom users: a qualitative analysis. J Psychoactive Drugs. 2015;47(5):360–367.
   PubMed Web of Science ®Google Scholar
• Smith KE, Rogers JM, Schriefer D, Grundmann O. Perceived therapeutic benefits with caveats?: analyzing social media data to understand complexities of kratom use. Drug Alcohol Depend. 2021;226:108879.
   PubMed Web of Science ®Google Scholar
• Brett EI, Stevens EM, Wagener TL, et al. A content analysis of JUUL discussions on social media: using Reddit to understand patterns and perceptions of JUUL use. Drug Alcohol Depend. 2019;194:358–362.
   PubMed Web of Science ®Google Scholar
• Bunting AM, Frank D, Arshonsky J, Bragg MA, Friedman SR, Krawczyk N. Socially-supportive norms and mutual aid of people who use opioids: an analysis of Reddit during the initial COVID-19 pandemic. Drug Alcohol Depend. 2021;222:108672.
   PubMed Web of Science ®Google Scholar
• Chandrasekharan E, Samory M, Jhaver S, et al. The Internet’s hidden rules: an empirical study of Reddit norm violations at micro, meso, and macro scales. Proc Acm Hum-Comput Interact. 2018;2:1–25.
   Google Scholar
• Sowles SJ, McLeary M, Optican A, et al. A content analysis of an online pro-eating disorder community on Reddit. Body Image. 2018;24:137–144.
   PubMed Web of Science ®Google Scholar
• Vosburg SK, Robbins RS, Antshel KM, Faraone SV, Green JL. Characterizing pathways of non-oral prescription stimulant non-medical use among adults recruited from Reddit. Front Psychiatry. 2020;11:631792.
   PubMed Web of Science ®Google Scholar
• Wojcik S, Messing S, Smith A, Rainie L, Hitlin P. Bots in the Twittersphere. Pew Research Center Website. http://assets.pewresearch.org/wpcontent/uploads/sites/14/2018/04/06160833/PI_2018. 2018
   Google Scholar
• MAXQDA 2020 [computer software]. Software V. Berlin, Germany: VERBI Software, Germany; 2020.
   Google Scholar
• Brennan RL, Prediger DJ. Coefficient kappa: some uses, misuses, and alternatives. Educational and Psychological Measurement. 1981;41(3):687–699.
   Web of Science ®Google Scholar
• McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276–282.
   PubMed Web of Science ®Google Scholar
• Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measure. 1960;20(1):37–46.
   Web of Science ®Google Scholar
• von Eye A, Von Eye M. Can one use Cohen’s kappa to examine disagreement. ? Methodology. 2005;1(4):129–142.
   Google Scholar
• Trakulsrichai S, Sathirakul K, Auparakkitanon S, et al. Pharmacokinetics of mitragynine in man. Drug Des Devel Ther. 2015;9:2421–2429.
   PubMed Web of Science ®Google Scholar
• Prozialeck WC. Update on the pharmacology and legal status of kratom. J Am Osteopath Assoc. 2016;116(12):802–809.
   PubMed Web of Science ®Google Scholar
• Chittrakarn S, Penjamras P, Keawpradub N. Quantitative analysis of mitragynine, codeine, caffeine, chlorpheniramine and phenylephrine in a kratom (Mitragyna speciosa Korth.) cocktail using high-performance liquid chromatography. Forensic Sci Int. 2012;217(1–3):81–86.
   PubMed Web of Science ®Google Scholar
• Fowble KL, Musah RA. A validated method for the quantification of mitragynine in sixteen commercially available kratom (Mitragyna speciosa) products. Forensic Sci Int. 2019;299:195–202.
   PubMed Web of Science ®Google Scholar
• Scott TM, Yeakel JK, Logan BK. Identification of mitragynine and O-desmethyltramadol in Kratom and legal high products sold online. Drug Test Anal. 2014;6(9):959–963.
   PubMed Web of Science ®Google Scholar
• Singh D, Yeou Chear NJ, Narayanan S, et al. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users. J Ethnopharmacol. 2020;249:112462.
   PubMed Web of Science ®Google Scholar
• Wilson LL, Chakraborty S, Eans SO, et al. Kratom alkaloids, natural and semi-synthetic, show less physical dependence and ameliorate opioid withdrawal. Cell Mol Neurobiol. 2021;41(5):1131–1143.
   PubMed Web of Science ®Google Scholar
• Smith KE, Rogers JM, Shriefer D, Grundmann O. Therapeutic benefit with caveats?: analyzing social media data to understand the complexities of kratom use. Drug Alcohol Depend. 2021;226:108879.
   PubMed Web of Science ®Google Scholar
• Brown J, West R, Beard E, Michie S, Shahab L, McNeill A. Prevalence and characteristics of e-cigarette users in Great Britain: findings from a general population survey of smokers. Addict Behav. 2014;39(6):1120–1125.
   PubMed Web of Science ®Google Scholar